{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:16:00Z","timestamp":1790381760395,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T00:00:00Z","timestamp":1462838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T00:00:00Z","timestamp":1462838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lassa fever is a severe multisystem disease that often has haemorrhagic manifestations. The epitopes of the Lassa virus (LASV) surface glycoproteins recognized by naturally infected human hosts have not been identified or characterized. Here we have cloned 113 human monoclonal antibodies (mAbs) specific for LASV glycoproteins from memory B cells of Lassa fever survivors from West Africa. One-half bind the GP2 fusion subunit, one-fourth recognize the GP1 receptor-binding subunit and the remaining fourth are specific for the assembled glycoprotein complex, requiring both GP1 and GP2 subunits for recognition. Notably, of the 16 mAbs that neutralize LASV, 13 require the assembled glycoprotein complex for binding, while the remaining 3 require GP1 only. Compared with non-neutralizing mAbs, neutralizing mAbs have higher binding affinities and greater divergence from germline progenitors. Some mAbs potently neutralize all four LASV lineages. These insights from LASV human mAb characterization will guide strategies for immunotherapeutic development and vaccine design.<\/jats:p>","DOI":"10.1038\/ncomms11544","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T06:07:18Z","timestamp":1462860438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":175,"title":["Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits"],"prefix":"10.1038","volume":"7","author":[{"given":"James E.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael E.","family":"Yenni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah H.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Rouelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrika B.","family":"Kannadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Smira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney E.","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8064-9314","authenticated-orcid":false,"given":"Benjamin T.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haini","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt L.","family":"Boisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Zandonatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mart\u00ednez-Sobrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian G.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Goba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mambu","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Fullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gbakie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lansana","family":"Kanneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica J.","family":"Koroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fonnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simbirie C.","family":"Jalloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brima","family":"Kargbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Vandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoh","family":"Gbetuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odia","family":"Ikponmwosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny A.","family":"Asogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter O.","family":"Okokhere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onikepe A.","family":"Follarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Schieffelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Kulakoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell B.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T.","family":"Happi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardis C.","family":"Sabeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahr M.","family":"Gevao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Humarr","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald S.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"BFncomms11544_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.185.4147.263","volume":"185","author":"TP Monath","year":"1974","unstructured":"Monath, T. P., Newhouse, V. F., Kemp, G. E., Setzer, H. W. & Cacciapuoti, A. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185, 263\u2013265 (1974).","journal-title":"Science"},{"key":"BFncomms11544_CR2","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","volume":"327","author":"JK Richmond","year":"2003","unstructured":"Richmond, J. K. & Baglole, D. J. Lassa fever: epidemiology, clinical features, and social consequences. BMJ 327, 1271\u20131275 (2003).","journal-title":"BMJ"},{"key":"BFncomms11544_CR3","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","volume":"162","author":"KG Andersen","year":"2015","unstructured":"Andersen, K. G. et al. Clinical sequencing uncovers origins and evolution of Lassa virus. Cell 162, 738\u2013750 (2015).","journal-title":"Cell"},{"key":"BFncomms11544_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1128\/JCM.01891-10","volume":"49","author":"DU Ehichioya","year":"2011","unstructured":"Ehichioya, D. U. et al. Current molecular epidemiology of Lassa virus in Nigeria. J. Clin. Microbiol. 49, 1157\u20131161 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"BFncomms11544_CR5","doi-asserted-by":"publisher","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","volume":"8","author":"JG Shaffer","year":"2014","unstructured":"Shaffer, J. G. et al. Lassa fever in post-conflict Sierra Leone. PLoS Negl. Trop. Dis. 8, e2748 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFncomms11544_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1126\/science.351.6268.16","volume":"351","author":"J Cohen","year":"2016","unstructured":"Cohen, J. Unfilled vials. Science 351, 16\u201319 (2016).","journal-title":"Science"},{"key":"BFncomms11544_CR7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2015.01.041","volume":"160","author":"T Hashiguchi","year":"2015","unstructured":"Hashiguchi, T. et al. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell 160, 904\u2013912 (2015).","journal-title":"Cell"},{"key":"BFncomms11544_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature07082","volume":"454","author":"JE Lee","year":"2008","unstructured":"Lee, J. E. et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177\u2013182 (2008).","journal-title":"Nature"},{"key":"BFncomms11544_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1126\/science.1186430","volume":"328","author":"R Xu","year":"2010","unstructured":"Xu, R. et al. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328, 357\u2013360 (2010).","journal-title":"Science"},{"key":"BFncomms11544_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature12966","volume":"507","author":"BE Correia","year":"2014","unstructured":"Correia, B. E. et al. Proof of principle for epitope-focused vaccine design. Nature 507, 201\u2013206 (2014).","journal-title":"Nature"},{"key":"BFncomms11544_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12250-013-3313-x","volume":"28","author":"Z Zhu","year":"2013","unstructured":"Zhu, Z. et al. Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1. Virol. Sin. 28, 71\u201380 (2013).","journal-title":"Virol. Sin."},{"key":"BFncomms11544_CR12","doi-asserted-by":"publisher","first-page":"13385","DOI":"10.1128\/JVI.01785-07","volume":"81","author":"J York","year":"2007","unstructured":"York, J. & Nunberg, J. H. A novel zinc-binding domain is essential for formation of the functional Junin virus envelope glycoprotein complex. J. Virol. 81, 13385\u201313391 (2007).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR13","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.1128\/JVI.07241-11","volume":"86","author":"EL Messina","year":"2012","unstructured":"Messina, E. L., York, J. & Nunberg, J. H. Dissection of the role of the stable signal peptide of the arenavirus envelope glycoprotein in membrane fusion. J. Virol. 86, 6138\u20136145 (2012).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR14","doi-asserted-by":"crossref","unstructured":"Hastie, K. M. et al. Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV. Nat. Struct. Mol. Biol, doi:10.1038\/nsmb.3210 (2016).","DOI":"10.2210\/pdb5ine\/pdb"},{"key":"BFncomms11544_CR15","doi-asserted-by":"publisher","first-page":"19967","DOI":"10.1073\/pnas.1108910108","volume":"108","author":"S Igonet","year":"2011","unstructured":"Igonet, S. et al. X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc. Natl Acad. Sci. USA 108, 19967\u201319972 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11544_CR16","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.1128\/JVI.00651-15","volume":"89","author":"H Cohen-Dvashi","year":"2015","unstructured":"Cohen-Dvashi, H., Cohen, N., Israeli, H. & Diskin, R. Molecular mechanism for LAMP1 recognition by Lassa virus. J. Virol. 89, 7584\u20137592 (2015).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR17","doi-asserted-by":"publisher","first-page":"e1005276","DOI":"10.1371\/journal.ppat.1005276","volume":"11","author":"R Sommerstein","year":"2015","unstructured":"Sommerstein, R. et al. Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection. PLoS Pathog. 11, e1005276 (2015).","journal-title":"PLoS Pathog."},{"key":"BFncomms11544_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2014.04.008","volume":"40","author":"C Blattner","year":"2014","unstructured":"Blattner, C. et al. Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. Immunity 40, 669\u2013680 (2014).","journal-title":"Immunity"},{"key":"BFncomms11544_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0042-6822(83)90135-6","volume":"130","author":"M Bruns","year":"1983","unstructured":"Bruns, M., Cihak, J., Muller, G. & Lehmann-Grube, F. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology 130, 247\u2013251 (1983).","journal-title":"Virology"},{"key":"BFncomms11544_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0042-6822(88)90616-2","volume":"164","author":"EL Weber","year":"1988","unstructured":"Weber, E. L. & Buchmeier, M. J. Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses. Virology 164, 30\u201338 (1988).","journal-title":"Virology"},{"key":"BFncomms11544_CR21","doi-asserted-by":"publisher","first-page":"11650","DOI":"10.1128\/JVI.00955-07","volume":"81","author":"B Eschli","year":"2007","unstructured":"Eschli, B. et al. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus. J. Virol. 81, 11650\u201311657 (2007).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1099\/0022-1317-72-3-549","volume":"72","author":"SL Ruo","year":"1991","unstructured":"Ruo, S. L. et al. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J. Gen. Virol. 72, 549\u2013555 (1991).","journal-title":"J. Gen. Virol."},{"key":"BFncomms11544_CR23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/jvi.61.4.982-985.1987","volume":"61","author":"MJ Buchmeier","year":"1987","unstructured":"Buchmeier, M. J., Southern, P. J., Parekh, B. S., Wooddell, M. K. & Oldstone, M. B. Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins. J. Virol. 61, 982\u2013985 (1987).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0042-6822(86)90020-6","volume":"153","author":"BS Parekh","year":"1986","unstructured":"Parekh, B. S. & Buchmeier, M. J. Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins. Virology 153, 168\u2013178 (1986).","journal-title":"Virology"},{"key":"BFncomms11544_CR25","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.4049\/jimmunol.162.8.4536","volume":"162","author":"P Seiler","year":"1999","unstructured":"Seiler, P. et al. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody. J. Immunol. 162, 4536\u20134541 (1999).","journal-title":"J. Immunol."},{"key":"BFncomms11544_CR26","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1128\/JVI.02700-09","volume":"84","author":"J York","year":"2010","unstructured":"York, J. et al. An antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion. J. Virol. 84, 6119\u20136129 (2010).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2015.11.005","volume":"18","author":"S Mahmutovic","year":"2015","unstructured":"Mahmutovic, S. et al. Molecular basis for antibody-mediated neutralization of new world hemorrhagic fever Mammarenaviruses. Cell Host Microbe 18, 705\u2013713 (2015).","journal-title":"Cell Host Microbe"},{"key":"BFncomms11544_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick, J. B. et al. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314, 20\u201326 (1986).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms11544_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(84)90299-X","volume":"2","author":"DA Enria","year":"1984","unstructured":"Enria, D. A., Briggiler, A. M., Fernandez, N. J., Levis, S. C. & Maiztegui, J. I. Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma. Lancet 2, 255\u2013256 (1984).","journal-title":"Lancet"},{"key":"BFncomms11544_CR30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/iai.44.2.528-533.1984","volume":"44","author":"PB Jahrling","year":"1984","unstructured":"Jahrling, P. B. & Peters, C. J. Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. Infect. Immun. 44, 528\u2013533 (1984).","journal-title":"Infect. Immun."},{"key":"BFncomms11544_CR31","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","volume":"46","author":"X Wei","year":"2002","unstructured":"Wei, X. et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46, 1896\u20131905 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms11544_CR32","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2008-09-177139","volume":"113","author":"XM Luo","year":"2009","unstructured":"Luo, X. M. et al. Engineering human hematopoietic stem\/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. Blood 113, 1422\u20131431 (2009).","journal-title":"Blood"},{"key":"BFncomms11544_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/JVI.02273-12","volume":"87","author":"JM Costin","year":"2013","unstructured":"Costin, J. M. et al. Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop. J. Virol. 87, 52\u201366 (2013).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR34","doi-asserted-by":"publisher","first-page":"12115","DOI":"10.1128\/JVI.01632-12","volume":"86","author":"R Kong","year":"2012","unstructured":"Kong, R. et al. Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies. J. Virol. 86, 12115\u201312128 (2012).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jviromet.2009.02.014","volume":"158","author":"HX Liao","year":"2009","unstructured":"Liao, H. X. et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J. Virol. Methods 158, 171\u2013179 (2009).","journal-title":"J. Virol. Methods"},{"key":"BFncomms11544_CR36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nprot.2009.3","volume":"4","author":"K Smith","year":"2009","unstructured":"Smith, K. et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4, 372\u2013384 (2009).","journal-title":"Nat. Protoc."},{"key":"BFncomms11544_CR37","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1073\/pnas.0813392106","volume":"106","author":"Y Guan","year":"2009","unstructured":"Guan, Y. et al. Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection. Proc. Natl Acad. Sci. USA 106, 3952\u20133957 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11544_CR38","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1128\/JVI.76.12.6393-6397.2002","volume":"76","author":"KJ Lee","year":"2002","unstructured":"Lee, K. J., Perez, M., Pinschewer, D. D. & de la Torre, J. C. Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J. Virol. 76, 6393\u20136397 (2002).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1743-422X-5-161","volume":"5","author":"MM Illick","year":"2008","unstructured":"Illick, M. M. et al. Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding. Virol J. 5, 161 (2008).","journal-title":"Virol J."},{"key":"BFncomms11544_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pep.2005.09.022","volume":"45","author":"RM Benoit","year":"2006","unstructured":"Benoit, R. M., Wilhelm, R. N., Scherer-Becker, D. & Ostermeier, C. An improved method for fast, robust, and seamless integration of DNA fragments into multiple plasmids. Protein Expr. Purif. 45, 66\u201371 (2006).","journal-title":"Protein Expr. Purif."},{"key":"BFncomms11544_CR41","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1128\/JVI.02229-10","volume":"85","author":"WW Rodrigo","year":"2011","unstructured":"Rodrigo, W. W., de la Torre, J. C. & Martinez-Sobrido, L. Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J. Virol. 85, 1684\u20131695 (2011).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR42","doi-asserted-by":"publisher","first-page":"e67484","DOI":"10.1371\/journal.pone.0067484","volume":"8","author":"I Bontjer","year":"2013","unstructured":"Bontjer, I. et al. Comparative immunogenicity of Evolved V1V2-deleted HIV-1 envelope glycoprotein trimers. PLoS ONE 8, e67484 (2013).","journal-title":"PLoS ONE"},{"key":"BFncomms11544_CR43","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1128\/jvi.69.9.5723-5733.1995","volume":"69","author":"R Wyatt","year":"1995","unstructured":"Wyatt, R. et al. Involvement of the V1\/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J. Virol. 69, 5723\u20135733 (1995).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1472-6750-8-91","volume":"8","author":"H Liu","year":"2008","unstructured":"Liu, H. & Naismith, J. H. An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 8, 91 (2008).","journal-title":"BMC Biotechnol."},{"key":"BFncomms11544_CR45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307\u2013312 (2003).","journal-title":"Nature"},{"key":"BFncomms11544_CR46","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1128\/JVI.02617-09","volume":"84","author":"JE Robinson","year":"2010","unstructured":"Robinson, J. E. et al. Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian\/human immunodeficiency virus SHIVSF162P4. J. Virol. 84, 3443\u20133453 (2010).","journal-title":"J. Virol."},{"key":"BFncomms11544_CR47","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/iai.37.2.771-778.1982","volume":"37","author":"PB Jahrling","year":"1982","unstructured":"Jahrling, P. B., Smith, S., Hesse, R. A. & Rhoderick, J. B. Pathogenesis of Lassa virus infection in guinea pigs. Infect. Immun. 37, 771\u2013778 (1982).","journal-title":"Infect. Immun."},{"key":"BFncomms11544_CR48","doi-asserted-by":"publisher","first-page":"W252","DOI":"10.1093\/nar\/gku340","volume":"42","author":"M Biasini","year":"2014","unstructured":"Biasini, M. et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 42, W252\u2013W258 (2014).","journal-title":"Nucleic Acids Res."},{"key":"BFncomms11544_CR49","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D"},{"key":"BFncomms11544_CR50","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/978-1-61779-842-9_32","volume":"882","author":"E Alamyar","year":"2012","unstructured":"Alamyar, E., Duroux, P., Lefranc, M. P. & Giudicelli, V. IMGT((R)) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT\/V-QUEST and IMGT\/HighV-QUEST for NGS. Methods Mol. Biol. 882, 569\u2013604 (2012).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms11544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11544","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T06:26:39Z","timestamp":1672813599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms11544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,1]]}},"alternative-id":["BFncomms11544"],"URL":"https:\/\/doi.org\/10.1038\/ncomms11544","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726345269.793555411","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]},"assertion":[{"value":"15 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Viral Hemorrhagic Fever Consortium (\n                      \n                      ) is a public-private partnership of academic and industry scientists who are developing diagnostic tests, therapeutic agents and vaccines for Lassa fever, Ebola and other severe diseases. Tulane University and its various academic and industry partners have filed United States and foreign patent applications on behalf of the VHFC for several technologies that have resulted from these efforts. Technical information may also be kept as trade secrets. If commercial products are developed, consortium members may receive royalties or profits. This does not alter our adherence to all policies of the National Institutes of Health and on sharing data and materials.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11544"}}